BR9710728A - Processos para regulação de metabolimo de nicotina - Google Patents

Processos para regulação de metabolimo de nicotina

Info

Publication number
BR9710728A
BR9710728A BR9710728-0A BR9710728A BR9710728A BR 9710728 A BR9710728 A BR 9710728A BR 9710728 A BR9710728 A BR 9710728A BR 9710728 A BR9710728 A BR 9710728A
Authority
BR
Brazil
Prior art keywords
processes
regulation
nicotine metabolism
metabolism
nicotine
Prior art date
Application number
BR9710728-0A
Other languages
English (en)
Inventor
Edward M Sellers
Rachel F Tyndale
Original Assignee
Nicogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicogen Inc filed Critical Nicogen Inc
Publication of BR9710728A publication Critical patent/BR9710728A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)

Abstract

Patente de Invenção para "PROCESSOS PARA REGULAçãO DO METABOLISMO DE NICOTINA" Processo de regulação do metabolismo de nicotina em um indivíduo compreendendo seletivamente a inibição de CYP2A6.
BR9710728-0A 1996-07-17 1997-07-17 Processos para regulação de metabolimo de nicotina BR9710728A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2194096P 1996-07-17 1996-07-17
PCT/CA1997/000506 WO1998003171A2 (en) 1996-07-17 1997-07-17 Use of inhibitors of cyp2a6 for regulating nicotine metabolism

Publications (1)

Publication Number Publication Date
BR9710728A true BR9710728A (pt) 2000-10-31

Family

ID=21806974

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710728-0A BR9710728A (pt) 1996-07-17 1997-07-17 Processos para regulação de metabolimo de nicotina

Country Status (8)

Country Link
EP (1) EP0954304A2 (pt)
JP (1) JP2000515516A (pt)
CN (1) CN100502860C (pt)
AU (1) AU742628B2 (pt)
BR (1) BR9710728A (pt)
CA (1) CA2227423A1 (pt)
NZ (1) NZ334205A (pt)
WO (1) WO1998003171A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999027919A2 (en) † 1997-07-17 1999-06-10 Nicogen Inc. Cyp2a enzymes and their use in therapeutic and diagnostic methods
US6492115B1 (en) 2000-06-02 2002-12-10 Dna Sciences Laboratories, Inc. Genetic typing of the human cytochrome P450 2A6 gene and related materials and methods
WO2005066162A1 (en) * 2003-12-23 2005-07-21 Human Biomolecular Research Institute Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
CN106046015B (zh) * 2016-06-08 2018-06-05 北京大学 一类细胞色素p450 2a6酶的特异性探针底物及其应用
CN112391397B (zh) * 2020-11-25 2023-01-31 云南中烟工业有限责任公司 一种烟草黄酮单加氧酶基因NtCYP75B2及其应用
CN114646718A (zh) * 2022-04-07 2022-06-21 国家烟草质量监督检验中心 一种人群使用口含烟产品时经口腔途径、消化道途径吸收的烟碱代谢动力学评价方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034679A2 (en) * 1994-06-16 1995-12-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Defects in drug metabolism

Also Published As

Publication number Publication date
CN1230112A (zh) 1999-09-29
AU3432097A (en) 1998-02-10
WO1998003171A3 (en) 1998-02-26
CA2227423A1 (en) 1998-01-29
JP2000515516A (ja) 2000-11-21
WO1998003171A2 (en) 1998-01-29
NZ334205A (en) 2001-04-27
CN100502860C (zh) 2009-06-24
EP0954304A2 (en) 1999-11-10
AU742628B2 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
EP0641204A4 (en) 17-ETHERS AND THIOETHERS OF 4-AZA-STEROIDES.
DK0867184T3 (da) Anvendelse af tiagabin til behandling af søvnforstyrrelser
LV12438A (en) Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof
DE69532804D1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
MD1745C2 (ro) 4,5-dimetil-N-2-propenil-2-(trimetilsilil)-3-tiofencarboxamidă, compoziţie fungicidă pe baza ei şi metodă de combatere a bolilor de plante
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
DE69831000D1 (de) Verwendung von cytidin und cytosin-enthaltenden verbindungen zur behandlung von reizmittelgelgebrauch
IL135584A0 (en) Method for treating alzheimer's disease
BR9710728A (pt) Processos para regulação de metabolimo de nicotina
CY2386B1 (en) Use of glyceryl triacetate for treating onychomycoses.
AU5558696A (en) Article and method for dilating respiratory passages
DE59510667D1 (de) Pyridylthioverbindungen zur bekämpfung von helicobacter-bakterien
ATE151980T1 (de) Zusammensetzung zur haarpflege
DK0655243T3 (da) Melatoninderivater til anvendelse ved behandling af søvnlidelser
DE69331546D1 (de) Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen
NO306262B1 (no) FremgangsmÕte for hydrogenbehandling
EP0687470A3 (en) Compounds for the treatment of metabolic bone diseases
ITFI930260A0 (it) Processo per l'estrazione e purificazione dell'alfal-antitripsina (alfal-pi)dalla frazione iv-1 di cohn.
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
KR970012155U (ko) 여성용 피부미용 세안팩
FR2721506B1 (fr) Composition pour le traitement des cheveux et procédé pour la préparation d'une lotion utilisant ladite composition.
HUP9800324A1 (hu) A háziméhek varroa-atka betegsége gyógykezelésének segédeszköze
IT1283267B1 (it) "apparecchio per trattare calzature."
GEP20002034B (en) Analogs of Keratinocyte Growth Factor
NO984964L (no) Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og ved depresjon

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B07A Technical examination (opinion): publication of technical examination (opinion)
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFERIMENTO DE ACORDO COM ART. 8O DA LPI.